STAAR Surgical Company

NASDAQ:STAA

Medical - Instruments & Supplies

Healthcare
$25.35 -1.37%

-$0.40 today

Market cap
$1.27B
Beta
1.23
P/E (TTM)
-68.3
EPS (TTM)
-$0.42
52W Low $15.59High $35.87

Volume 0.45M

Average 1.07M

STAA Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

STAAR Surgical CompanyNASDAQ: STAA

Gross Margin · Q1 FY2026 · quarter ended Apr 2026

Gross margin widens to 72.2%

Gross margin was 72.2% in Q1 FY2026, up 6.4 pp from a year earlier. On a trailing-twelve-month basis it was 76.4%, up 2.4 pp year over year. Over 3 fiscal years it narrowed by 2.4 pp.

Context

  • Gross margin widened in 0 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterApr 2026
72.2%-3.5 pp QoQ
Last fiscal yearJan 2026
76.2%-0.1 pp YoY
LTMApr 2026
76.4%+2.4 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+6.4 pp——
1 year-0.1 pp——
3 years-2.4 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
76.2%
Year-over-year change
-0.1pp

Gross Margin vs competitors

How STAA compares with its peers on the latest reported figures

  • STAA's LTM Apr 2026 gross margin of 76.4% is the 2nd highest of the 5 companies compared; the peer median is 60.5%.
  • Its year-over-year change of +2.4 pp is the 2nd highest of 5, against a peer median of +1.2 pp.
  • Over three fiscal years its change of -2.4 pp compares with a peer median of -1.6 pp.
STAA Competitors Peer median
Gross Margin for STAA and competitors
Company Period LTM level YoY 3-year change
RXSTRxSight, Inc.LTM Mar 202677.0% +9.7 pp+33.1 pp
STAASTAAR Surgical CompanyLTM Apr 202676.4% +2.4 pp-2.4 pp
COOThe Cooper Companies, Inc.LTM Jul 202663.6% -3.3 pp-4.0 pp
ALCAlcon Inc.LTM Sep 202657.3% +2.2 pp+0.8 pp
BLCOBausch + Lomb CorporationLTM Jun 202657.2% +0.3 pp-4.9 pp
Peer median (excluding STAA) 60.5%+1.2 pp-1.6 pp

Competitors are the stored peer set for STAA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Jan 2026
Revenue230.47M284.39M322.42M313.9M239.44M
Cost of Revenue51.84M61.01M69.76M74.32M57.02M
Gross Profit178.64M223.38M252.65M239.58M182.42M
Gross Margin77.5%78.5%78.4%76.3%76.2%
Research & Development33.86M35.98M44.4M53.97M40.06M
Selling, General & Admin111.44M143.6M180.15M198.22M188.31M
Operating Expenses145.3M179.58M224.55M252.19M228.37M
Depreciation & Amortization3.64M4.51M5.12M6.89M8.73M
EBITDA34.98M50.06M38.82M(2.16M)(73.54M)
EBITDA Margin15.2%17.6%12.0%-0.7%-30.7%
Operating Income33.34M43.8M28.1M(12.61M)(45.95M)
Operating Margin14.5%15.4%8.7%-4.0%-19.2%
Interest Income—2.45M6.99M5.91M4.59M
Interest Expense38K0000
Other Income / Expenses(2.04M)1.75M5.6M3.56M(36.32M)
Income Before Tax31.3M45.55M33.7M(9.05M)(82.26M)
Pre-Tax Margin13.6%16.0%10.5%-2.9%-34.4%
Income Tax Expense3.79M5.89M12.35M11.16M(1.82M)
Net Income27.51M39.67M21.35M(20.21M)(80.45M)
Net Margin11.9%13.9%6.6%-6.4%-33.6%
EPS (Basic)0.520.830.44(0.41)(1.62)
EPS (Diluted)0.500.800.43(0.41)(1.62)
Weighted Avg Shares47.21M47.99M48.52M49.13M49.57M
Weighted Avg Shares (Diluted)49.46M49.38M49.43M49.13M49.57M

STAAR Surgical Company

NASDAQ:STAA

Intrinsic Alpha fair value

Locked

Current Price

$25.35

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.